Arca
Skip to content
Tools
Tools

FOLP: Dihydropteroate synthase

Protein in Bacteria that 18 drugs act on.

  • Drugs that act on it: 18
  • Approved: 17
  • In phases 1 to 3: 1
  • Sponsors: 10

Who is on it, and how far along

Every drug ChEMBL records acting on FOLP, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 18

Approved17

  • Sulfamethazine
  • Sulfamethoxazole
  • Sulfalene
  • Sulfameter
  • Sulfadiazine
  • Mafenide
  • Sulfacetamide
  • Sulfadimethoxine
  • Sulfamerazine
  • Sulfamethizole
  • Sulfamethoxypyridazine
  • Sulfanilamide
  • Sulfaphenazole
  • Sulfapyridine
  • Sulfathiazole
  • Sulfisoxazole
  • Sulfisoxazole acetyl

Phase 31

  • Co-trimoxazole

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • DiproBio (Shanghai) Co., Ltd.16%
      • Skingenix, Inc.16%

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Bacterial dihydropteroate synthase inhibitor.
      SulfamethazineWithdrawnApproved—Small moleculeInhibitor99
      SulfamethoxazoleApprovedRocheSmall moleculeInhibitor52
      SulfaleneApprovedDiproBio (Shanghai) Co., Ltd.Small moleculeInhibitor49
      SulfameterApprovedBayerSmall moleculeInhibitor8
      SulfadiazineApprovedSkingenix, Inc.Small moleculeInhibitor5
      MafenideApprovedRising PharmaceuticalsSmall moleculeInhibitor0
      SulfacetamideApprovedMerck & Co. (MSD)Small moleculeInhibitor0
      SulfadimethoxineWithdrawnApproved—Small moleculeInhibitor0
      SulfamerazineWithdrawnApproved—Small moleculeInhibitor0
      SulfamethizoleWithdrawnApprovedPfizerSmall moleculeInhibitor0
      SulfamethoxypyridazineWithdrawnApproved—Small moleculeInhibitor0
      SulfanilamideApprovedPharmoBedientSmall moleculeInhibitor0
      SulfaphenazoleApprovedPurdue PharmaSmall moleculeInhibitor0
      SulfapyridineApprovedEli LillySmall moleculeInhibitor0
      SulfathiazoleWithdrawnApproved—Small moleculeInhibitor0
      SulfisoxazoleApprovedRocheSmall moleculeInhibitor0
      Sulfisoxazole acetylApprovedRocheSmall moleculeInhibitor0
      Co-trimoxazolePhase 3Merck & Co. (MSD)Small moleculeInhibitor55

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 38 in all, from ClinicalTrials.gov.
      Effects of Inulin-Based Prebiotics on Gut Microbiota After Rectal Cancer SurgerySulfaleneNot applicableNot yet recruitingPeking Union Medical College HospitalNov 20, 2026
      Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin DiseasesSulfameter—RecruitingFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoNov 18, 2026
      Effects of Synbiotic Supplementation on Adipose Tissue Factors in Obese Women Undergoing Sleeve GastrectomySulfaleneNot applicableEnrolling by invitationTehran University of Medical SciencesNov 17, 2026
      Immediate Effects of PNF and Conventional Swallowing Exercises in Post-Stroke DysphagiaSulfamethazineNot applicableNot yet recruitingBezmialem Vakif UniversityNov 17, 2026
      Study the Mechanism and Effectiveness of Probiotics on Atopic DermatitisSulfaleneNot applicableEnrolling by invitationNational Cheng-Kung University HospitalNov 16, 2026
      Effects of a Combination of Bifidobacterium Longum Subsp. Longum Strains on Stress and Related Health Outcomes in Young AdultSulfaleneNot applicableNot yet recruitingDiproBio (Shanghai) Co., Ltd.Nov 16, 2026
      Effects of Bifidobacterium Longum Subsp. Infantis i18 on Gut Microbiota Development and Health in Early LifeSulfaleneNot applicableNot yet recruitingDiproBio (Shanghai) Co., Ltd.Nov 16, 2026
      Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible EnterobacteriaCo-trimoxazolePhase 3Not yet recruitingAssistance Publique - Hôpitaux de ParisNov 12, 2026
      Increasing Mothers' Own Milk Feeding in the Neonatal ICUSulfamethazineNot applicableRecruitingThe University of Texas Health Science Center, HoustonNov 12, 2026
      A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Sulfamethoxazole, Co-trimoxazolePhase 2 / Phase 3Not yet recruitingMerck Sharp & Dohme LLCNov 5, 2026
      Effect of Synbiotic Therapy on Renal Function Outcomes in Patients With Chronic Kidney Disease Stage III-IV: A Double-blind Randomized Placebo-controlled Trial.SulfaleneNot applicableRecruitingChittagong Medical CollegeNov 3, 2026
      Effects of Cervical SNAGs With and Without Thoracic Manipulation on Neck Pain and Disability in Smartphone UsersSulfamethazineNot applicableNot yet recruitingUniversity of Management and Technology LahoreNov 2, 2026
      National Registry of Noonan SyndromeSulfameter—RecruitingIstituto Giannina GasliniOct 19, 2026
      Comparison of Topical Antibiotics Versus Systemic Antibiotics in Preventing Burn Wound Infection in Pediatric Burn PatientsSulfadiazineNot applicableNot yet recruitingabdul mateenOct 13, 2026
      Personalized Probiotic Treatments for Irritable Bowel SyndromeSulfaleneNot applicableEnrolling by invitationMcMaster UniversityOct 13, 2026
      Effects of Incentive Spirometry Versus Diaphragmatic Breathing on Oxygen Saturation and Heart-rate Variability in Post Percutaneous Coronary Intervention PatientsSulfamethazineNot applicableRecruitingFoundation University IslamabadOct 9, 2026
      Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AMLSulfamethazinePhase 2Not yet recruitingRutgers, The State University of New JerseyOct 9, 2026
      A Real-world Study of Gastrointestinal Health and Mental Wellness in U.S. Adults Following 12 Weeks of Probiotic Supplementation.SulfaleneNot applicableNot yet recruitingNovonesisSep 30, 2026
      Increasing Engagement With Digital Behavioral HealthSulfamethazineNot applicableNot yet recruitingHackensack Meridian HealthSep 23, 2026
      Endurance Trial: Ketone and Carbohydrate SupplementationSulfamethazineNot applicableRecruitingUniversity of Sao PauloAug 28, 2026
      The Medically Tailored Groceries and Mental Health StudySulfamethazineNot applicableRecruitingUniversity of Massachusetts, WorcesterAug 21, 2026
      Drug-induced Crystalluria in Sulfamethoxazole, High Dose Ciprofloxacin and High Dose AmoxicillinSulfamethoxazoleNot applicableRecruitingUniversitair Ziekenhuis BrusselAug 19, 2026
      Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeSulfamethoxazole, Co-trimoxazolePhase 3Not yet recruitingChildren's Hospital of Fudan UniversityAug 14, 2026
      TMP-SMX for Non-HIV PCP: A Prospective Multicenter StudySulfamethoxazole, Co-trimoxazole—Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineJul 8, 2026
      Precision Management of Urinary Tract Symptoms in Older WomenSulfamethoxazole, Co-trimoxazolePhase 3RecruitingMegan BradleyJul 7, 2026
      Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPDSulfamethoxazole, Co-trimoxazoleNot applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineJun 24, 2026
      Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsSulfamethoxazole, Co-trimoxazoleEarly phase 1RecruitingThe Cleveland ClinicJun 15, 2026
      Frailty in the Elderly Oncological and Oncohematological Patient.Sulfameter—Enrolling by invitationAzienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di LegnanoJun 3, 2026
      Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney TransplantationSulfamethoxazole, Co-trimoxazolePhase 4Not yet recruitingAnhui Provincial HospitalJun 1, 2026
      Microenvironment in Patients Undergoing Non-traumatic AmputationSulfadiazineNot applicableRecruitingUniversity of AarhusFeb 3, 2026
      Silver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness BurnsSulfadiazineNot applicableNot yet recruitingDr Muhammad Naveed ShahzadJan 26, 2026
      Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)Sulfameter—RecruitingIRCCS Policlinico S. DonatoJul 31, 2025
      Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational StudySulfameter—RecruitingOspedale Policlinico San MartinoJul 11, 2025
      Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFRSulfameterNot applicableRecruitingSocieta Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente TrasmesseMar 11, 2025
      Protocollo N 2014 - Benign Prostatic HyperplasiaSulfameter—RecruitingIRCCS San RaffaeleDec 26, 2023
      Effects of Nutrition on Post Stroke FatigueSulfameterNot applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCSFeb 15, 2023
      Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal BurnsSulfadiazinePhase 2RecruitingSkingenix, Inc.Feb 16, 2011
      Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisSulfadiazinePhase 4RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)Oct 19, 1999

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364668, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.